Commentary: Can we depend on the point-of-care rapid antigen testing for SARS-CoV-2 for routine ophthalmic procedures and high volume ophthalmic settings?

Mishra, Deepak; Kaur, Kirandeep; Gurnani, Bharat

Mishra, Deepak; Kaur, Kirandeep; Gurnani, Bharat.

Mishra D; Regional Institute of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Kaur K; Cataract, Pediatric Ophthalmology and Squint Services, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India.
Gurnani B; Cataract, Cornea and Refractive Services, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India.

Indian J Ophthalmol ; 70(5): 1765-1766, 2022 05.

Article in English | MEDLINE | ID: covidwho-1835136

Subject(s)

COVID-19; SARS-CoV-2; Eye; Face; Humans; Point-of-Care Systems

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Indian J Ophthalmol Year: 2022 Document Type: Article Affiliation country: Ijo.IJO_757_22

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google